Skip to main content
Alkyl Amines Chemicals Ltd. logo

Alkyl Amines Chemicals Ltd. — Investor Relations & Filings

Ticker · ALKYLAMINE ISIN · INE150B01039 LEI · 335800Q3QM17QE7P1X04 BSE.NS Manufacturing
Open in API
Filings indexed 1,117 across all filing types
Latest filing 2026-05-15 Regulatory Filings
Country IN India
Listing BSE.NS ALKYLAMINE

About Alkyl Amines Chemicals Ltd.

https://alkylamines.com/

Alkyl Amines Chemicals Ltd. specializes in the manufacturing of aliphatic amines and their derivatives. The company produces a comprehensive range of methylamines, ethylamines, and higher alkyl amines, as well as specialty amine derivatives including amides, hydrochlorides, and esters. These products serve as essential intermediates for the pharmaceutical, agrochemical, water treatment, and rubber chemical sectors. The organization operates integrated manufacturing facilities and emphasizes research and development to support the synthesis of active pharmaceutical ingredients and crop protection agents. By leveraging advanced chemical processes and maintaining a robust supply chain, the company provides technical solutions and high-purity chemical components to a global client base across diverse application areas.

Recent filings

Filing Released Lang Actions
As per attachment
Regulatory Filings Classification · 95% confidence The document is an Annual Secretarial Compliance Report prepared by the company’s Practicing Company Secretary under Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements). It is a compliance certificate filed with the stock exchanges rather than a financial report (10-K/IR), management discussion (MDA), governance code, or other specific category. There is no explicit category for secretarial compliance reports, so it falls under the general Regulatory Filings category (RNS).
2026-05-15 English
As per attachment
Regulatory Filings Classification · 95% confidence The document is a formal clarification letter addressed to BSE Surveillance under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Rules, responding to an exchange query regarding a significant increase in share trading volume. It does not present financial statements, management discussion, or meeting materials, nor announce dividends, board changes, or transactions. It is a routine regulatory disclosure/filing under continuous listing obligations. This fits the Regulatory Filings (RNS) category.
2026-05-15 English
Spurt in Volume
Regulatory Filings Classification · 92% confidence The document is a formal response letter to the stock exchange (NSE) under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), providing clarification on unusual share volume movement. It contains no financial statements, management or audit information, or reporting of results; rather, it is a regulatory compliance filing. This falls under the general Regulatory Filings category (RNS).
2026-05-15 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 96% confidence The document is a full transcript of the Q4 FY26 earnings conference call (investor/analyst Q&A session) for Alkyl Amines Chemicals Limited, explicitly labeled as a “Transcript of Conference Call” and containing the call dialogue. This matches the definition of a Call Transcript (CT).
2026-05-13 English
As per attachment
Call Transcript Classification · 95% confidence The document is an official submission to stock exchanges enclosing the full text transcript of the Q4FY26 earnings conference call with investors and analysts. It includes moderator remarks, management presentations, and detailed Q&A. This matches the definition of a Call Transcript (Code: CT).
2026-05-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the availability of the audio recording of an earnings conference call held on May 6, 2026. It references the earnings call for the quarter and financial year ended March 31, 2026, and provides a link to the audio recording on the company's website. The document itself does not contain the transcript or detailed financial data but is an announcement about the availability of the call recording. The document length is short (1566 characters), and it serves as a notification rather than the full transcript or financial report. Therefore, it should be classified as a Call Transcript (CT) related announcement, but since it only announces the availability of the audio recording and does not contain the transcript itself, it fits best under Regulatory Filings (RNS) as a general regulatory announcement about the earnings call recording availability.
2026-05-06 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.